Intravitreal triamcinolone acetonide in the management of exogenous bacterial endophthalmitis.
OBJECTIVE
To determine the effectiveness of intravitreal triamcinolone acetonide in the management of bacterial endophthalmitis.


METHODS
Interventional case series.


METHODS
This pilot case series included five patients (three patients after trauma and two patients after cataract surgery) with culture proven bacterial endophthalmitis. After 48 to 72 hours of the initial surgical procedure, 4 mg/0.1 ml of intravitreal triamcinolone acetonide was injected, after confirmation that the vitreous isolate was sensitive to the initially administered intravitreal antibiotics. All patients received oral ciprofloxacin 750 mg twice each day for seven days. The course of inflammation and the clinical outcome were noted.


RESULTS
In all the five cases, there was complete resolution of inflammation with favorable clinical outcome at the end of one month that was maintained at the end of three months.


CONCLUSIONS
Intravitreal triamcinolone acetonide could be a treatment option in the selected cases of bacterial endophthalmitis.
Pathengay
Avinash
A
Smt Kanuri-Santhamma Retina Vitreous Centre, Hyderabad Eye Research Foundation, Prof. Brien Holden Eye Research Center, L.V. Prasad Eye Institute, L.V. Prasad Marg, Banjara Hills, Hyderabad 500-034, India. avinash@lvpei.org
Shah
Gaurav Yogesh
GY
Das
Taraprasad
T
Sharma
Savitri
S